Introduction: Prediction of neurodevelopmental outcome in infants with hypoxic-ischemic
encephalopathy remains an important challenge. Various studies have shown that the …

Background and Objective: There remains an unmet clinical need for markers that predict
outcomes in the hypothermia-treated (HT) infants with HIE. The aim of this meta-analysis …

Hypoxic–ischaemic encephalopathy (HIE) is a leading cause of acquired neonatal brain
injury. Assessment of the severity of cerebral injury and likely neurological outcome in …

Despite theprogress inperinatal care, perinatal asphyxia (PA) remains asignificant problem
inneonatology. Thedevelopment of therapeutic hypothermia (TH) has improved …

Objective To examine the effect of therapeutic hypothermia on MR biomarkers and
neurodevelopmental outcomes in babies with mild hypoxic-ischaemic encephalopathy …

Abstract Background: The so-called Thompson-score (TS) for newborns with hypoxic-
ischemic encephalopathy (HIE) was developed before the introduction of controlled …

Background Moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy
might improve survival and neurological outcomes at up to 18 months of age, although …

Objective To investigate the effects of hypothermia treatment on magnetic resonance
imaging (MRI) patterns of brain injury in newborns with hypoxic-ischemic encephalopathy …

OBJECTIVE. The goals were to identify predictor variables and to develop scoring systems
and classification trees to predict death/disability or death in infants with hypoxic-ischemic …

Aims Hypoxic ischaemic encephalopathy (HIE) remains a significant cause of long term
neurodisability despite therapeutic hypothermia (TH). Infants with mild HIE, representing …